ONCOREVEAL Trademark

Trademark Overview


On Wednesday, February 17, 2021, a trademark application was filed for ONCOREVEAL with the United States Patent and Trademark Office. The USPTO has given the ONCOREVEAL trademark a serial number of 90532971. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, September 9, 2024. This trademark is owned by Pillar Biosciences, Inc.. The ONCOREVEAL trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Data processing services for medical, clinical, and scientific purposes

Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics; genetic testing for medical and clinical medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical and clinical medical purposes, health and wellness assessment services; providing health and wellness information

Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagno...
oncoreveal

General Information


Serial Number90532971
Word MarkONCOREVEAL
Filing DateWednesday, February 17, 2021
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Pseudo MarkONCO REVEAL
Goods and ServicesData processing services for medical, clinical, and scientific purposes
Goods and ServicesProviding biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics; genetic testing for medical and clinical medical purposes; medical testing for diagnostic and treatment purposes; consulting services for medical and clinical medical purposes, health and wellness assessment services; providing health and wellness information
Goods and ServicesSoftware as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable computer software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable computer software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; data processing services for medical, clinical, and scientific purposes; developing diagnostic testing models for others for medical, clinical, and scientific purposes; Genetic testing for scientific research purposes; Scientific consulting relating to scientific research

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code035
First Use Anywhere DateWednesday, March 16, 2022
First Use In Commerce DateWednesday, March 16, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code044
First Use Anywhere DateWednesday, March 16, 2022
First Use In Commerce DateWednesday, March 16, 2022

Trademark Owner History


Party NamePillar Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Party NamePillar Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Saturday, February 20, 2021NEW APPLICATION ENTERED
Tuesday, February 23, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 23, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 11, 2021ASSIGNED TO EXAMINER
Tuesday, September 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 21, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, October 29, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, November 1, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, November 1, 2021EXAMINERS AMENDMENT E-MAILED
Monday, November 1, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 1, 2021EXAMINER'S AMENDMENT ENTERED
Monday, November 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 1, 2022TEAS STATEMENT OF USE RECEIVED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 1, 2022SOU EXTENSION 1 FILED
Monday, August 1, 2022USE AMENDMENT FILED
Wednesday, August 10, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 10, 2022SOU EXTENSION 1 GRANTED
Thursday, September 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 10, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 8, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, September 8, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 8, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 8, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 7, 2023ASSIGNED TO LIE
Friday, July 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 31, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, July 31, 2023NON-FINAL ACTION E-MAILED
Monday, July 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 30, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, October 30, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 30, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, January 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2024DIVISIONAL PROCESSING COMPLETE
Friday, March 8, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, March 8, 2024NON-FINAL ACTION E-MAILED
Friday, March 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED